AI Verdict
GILD has stronger fundamentals based on our AI analysis.
ABT vs GILD Fundamental Comparison
| Metric | ABT | GILD |
|---|---|---|
| Revenue | $44.3B | $29.4B |
| Net Income | $6.5B | $8.5B |
| Net Margin | 14.7% | 28.9% |
| ROE | 12.5% | 37.5% |
| ROA | 7.5% | 14.4% |
| Current Ratio | 1.58x | 1.55x |
| Debt/Equity | 0.25x | 1.10x |
| EPS | $3.72 | $6.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs GILD: Frequently Asked Questions
Is ABT or GILD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. ABT is rated BUY (77% confidence) while GILD is rated BUY (82% confidence). This is not investment advice.
How does ABT compare to GILD fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs GILEAD SCIENCES, INC.'s 37.5%. Net margins are 14.7% vs 28.9% respectively.
Which stock pays higher dividends, ABT or GILD?
ABT has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or GILD for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while GILD has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs GILD, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.